HOTH News and Press, Hoth Therapeutics Inc. From 08/05/20

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...

Hoth Therapeutics ( HOTH +11.4% ) inks an agreement with Isoprene, a University of Maryland, Baltimore New Venture Initiative startup, for the rights to VNLG-152, a novel retinamide, a retinoic acid metabolism block agent or RAMBA, for use in dermatology. More news on: Hoth Therapeutic...

NEW YORK , July 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has executed a licensing agreement with Isoprene Pharmaceuticals, Inc. to acquire the rights to VNLG-152, a novel retinamides (Retinoic acid...

Over 100 Presenting Companies Have Already Registered NEW YORK, NY / ACCESSWIRE / July 30, 2020 / Sidoti, among the preeminent providers of independent securities research to small- and micro-cap companies with about 200 names under coverage, is pleased to announce that its Fall 2020 Vi...

NEW YORK , July 09, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. (the Company) announced today it has retained Buenaventura Advisors, LLC to explore strategic alternatives for HaloVax, a biopharmaceutical company and special purpose subsidiary of Voltron Therapeutics, Inc.  ...

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today it has initiated preclinical animal testing of the first construct of its HaloVax Self-Assembling Vaccine (SAV) against COVID-19. Voltron will take two different vaccines, with differing sets of targe...

Hoth Therapeutics ( HOTH +2.8% )  announces  sponsored research agreement with Virginia Commonwealth University for development of a potential COVID-19 treatment. More news on: Hoth Therapeutics, Inc., Healthcare stocks news, Read more ...

NEW YORK , June 30, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced entering into a sponsored research agreement with Virginia Commonwealth University (VCU) for a potential COVID-19 treatment. Research wil...

NEW YORK , June 16, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company, today announced that it has expanded its sponsored research agreement with the George Washington University (GW) to explore the potential use of WEG232 for...

NEW YORK , June 15, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Scientific Advisory Board member and inventor of novel peptide COVID-19 therapeutic, Michael H. Peters , Ph.D., Professor, Department of Chemi...